DRGT is a specialty pharmaceutical company dedicated to the development and commercialization of high-value proprietary drugs that deliver measurable and meaningful improvements in clinical utility. DRGT utilizes its proprietary Super-API drug development platform to carefully select and screen drugs and develop their Super-API compositions. The Company’s Super-API portfolio contains 30 compounds in indications such as oncology, pain and erectile dysfunction with multi-$ billion potential. Super-API drugs are protected by global composition of matter IP. DRGT is incorporated in Ireland with R&D facilities in Budapest, Hungary.
View Top Employees from Druggability Technologies Holdings Ltd.| Website | http://www.drgtco.com/ |
| Revenue | $5 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2011 |
| Phone | (361) 577-9300 |
| Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Manufacturing & Research, Pharmaceutical, Pharmaceuticals, Health Care, Healthcare |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Druggability Technologies Holdings Ltd. employee's phone or email?
Druggability Technologies Holdings Ltd. Questions
The Druggability Technologies Holdings Ltd. annual revenue was $5 million in 2024.
Druggability Technologies Holdings Ltd. is based in Dublin, Leinster.
The NAICS codes for Druggability Technologies Holdings Ltd. are [54171, 541711, 54, 541, 5417].
The SIC codes for Druggability Technologies Holdings Ltd. are [283, 28, 2834].
Related Companies
